US FDA approves Amneal's self-administered migraine treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| (NASDAQ: AXSM) | Delayed: 170.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $170.08 | 52 Week High | $15.74 | |||
| Open | $170.08 | 52 Week Low | $5.37 | |||
| Day High | $170.08 | P/E | N/A | |||
| Day Low | $170.08 | EPS | $0.00 | |||
| Volume | 45 | |||||
